SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia
Wei Chen1, Jie Zhang2, Xijian Qin3, Weixiao Wang1, Miaomiao Xu4, Lin-Fa Wang5, Chuanjun Xu6, Shuangshuang Tang3, Pei Liu3, Libo Zhang7, Xuan Liu8, Yongchen Zhang8, Changhua Yi4, Zhiliang Hu4,9, Yongxiang Yi4
1Clinical Research Center, the Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003, China
2Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, 70 President Street, DDB410, Charleston, SC, 29425, USA
3GenScript Biotech, Nanjing, 210003, China
4Nanjing Infectious Disease Center, the Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003, China
5Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore
6Department of Radiology, the Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003, China
7Department of Laboratory Medicine, Nanjing Red Cross Blood Center, Nanjing, 210003, Jiangsu, China
8Department of Clinical Laboratory, the Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003, China
9Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Biomedicine & Pharmacotherapy
Tập 130
110629
Thông tin tác giả